drugset / Trial / NCT01348516
Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the safety and pharmacokinetics of KM-023 after single/multiple dosing.
Timeline
- Start
- 2011-05
- Primary completion
- 2012-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KM-023 | Unknown | 75 mg | Oral |
| Subject | KM-023 | Unknown | 150 mg | Oral |
| Subject | KM-023 | Unknown | 300 mg | Oral |
| Subject | KM-023 | Unknown | 600 mg | Oral |